High HIF-1α/PD-L1 expression levels were found in NSCLC tissue after traditional PDT, which may assist in predicting the prognosis of NSCLC patients treated by PDT and PD-1/PD-L1 therapy. The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.